Rockwell Medical, Inc.
Rockwell Medical, Inc. (Nasdaq: RMTI) develops, manufactures, commercializes and distributes hemodialysis products for dialysis providers and distributors in the United States and internationally. Its portfolio includes liquid and dry acid and bicarbonate concentrates, single-use bicarbonate cartridges, dry acid… From the company’s description.
Over the twelve months to Jun 30, 2026, Rockwell Medical, Inc. reported revenue of $69.39M, down 21.1% from a year earlier, and a net loss of $5.08M. Its operating margin was −6.5%, and operations generated $2.90M in cash. In fiscal 2025, it reported revenue of $69.26M, down 31.8% from fiscal 2024, and a net loss of $5.31M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Rockwell Medical, Inc. does
In the company’s own words
Rockwell Medical, Inc. (Nasdaq: RMTI) develops, manufactures, commercializes and distributes hemodialysis products for dialysis providers and distributors in the United States and internationally. Its portfolio includes liquid and dry acid and bicarbonate concentrates, single-use bicarbonate cartridges, dry acid concentrate mixers and ancillary supplies used in dialysis clinics, hospitals, skilled nursing facilities and home treatment. The concentrates are mixed with purified water to create dialysate, which is used to clean patients’ blood during hemodialysis. Rockwell serves 294 customers, including all five leading U.S. dialysis providers, and supplies distributors serving more than 30 countries. Dialysate concentrates accounted for all of the company’s revenue in 2025; approximately 88% of sales were to U.S. customers and distributors. It manufactures concentrates at facilities in Michigan and Texas and dry acid concentrate mixers in Iowa. Its product brands include CitraPure, Dri-Sate, RenalPure and SteriLyte. Its website is https://www.rockwellmed.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Pharmaceutical Preparations
- Headquarters
- WIXOM, MI
- Fiscal year end
- December
- CIK
- 1041024
- SIC
- 2834
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Rockwell Medical, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Rockwell Medical, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Rockwell Medical, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Rockwell Medical, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Rockwell Medical, Inc.'s last four quarterly filings that the numbers alone won't show?”